BACKGROUND/ PURPOSE: To assess correlation between brain lesions and clinical status with 1.5T and 3T magnetic resonance imaging (MRI). METHODS: Brain MRI fluid-attenuated inversion-recovery (FLAIR) sequences were performed in 32 multiple sclerosis (MS) patients. Expanded Disability Status Scale (EDSS) score (mean±standard deviation) was 2±2.0 (range 0-8), disease duration 9.3±8.0 (range .8-29) years. RESULTS: FLAIR lesion volume (FLLV) at 3T was higher than at 1.5T (P=.01). Correlation between 1.5T FLLV and EDSS score was poor, while 3T FLLV correlated moderately and significantly (rs=.39, P=.03). When controlling for age and depression, correlations between FLLV and cognitive measures were significant at 1.5T for the Judgment of Line Orientation test (JLO) (rs=-.44, P=.05), the Symbol Digit Modalities Test (SDMT) (rs=-.49, P=.02), and the California Verbal Learning Test Delayed Free Recall (CVLT DR) (rs=-.44, P=.04). Correlations at 3T were also significant for these tests, but of greater magnitude: JLO (rs=-.70, P=.0005), SDMT (rs=-.73, P=.0001), CVLT DR (rs=-.061, P=.003). Additional significant correlations obtained only at 3T included the 2 second-paced auditory serial addition test (rs=-.55, P=.01), the Brief Visuospatial Memory Test-Delayed Free Recall (rs=-.56, P=.007), and the California Verbal Learning Test Total Recall (rs=-.42, P=.05). CONCLUSION: MRI at 3T may boost sensitivity and improve validity in MS brain lesion assessment.
BACKGROUND/ PURPOSE: To assess correlation between brain lesions and clinical status with 1.5T and 3T magnetic resonance imaging (MRI). METHODS: Brain MRI fluid-attenuated inversion-recovery (FLAIR) sequences were performed in 32 multiple sclerosis (MS) patients. Expanded Disability Status Scale (EDSS) score (mean±standard deviation) was 2±2.0 (range 0-8), disease duration 9.3±8.0 (range .8-29) years. RESULTS: FLAIR lesion volume (FLLV) at 3T was higher than at 1.5T (P=.01). Correlation between 1.5T FLLV and EDSS score was poor, while 3T FLLV correlated moderately and significantly (rs=.39, P=.03). When controlling for age and depression, correlations between FLLV and cognitive measures were significant at 1.5T for the Judgment of Line Orientation test (JLO) (rs=-.44, P=.05), the Symbol Digit Modalities Test (SDMT) (rs=-.49, P=.02), and the California Verbal Learning Test Delayed Free Recall (CVLT DR) (rs=-.44, P=.04). Correlations at 3T were also significant for these tests, but of greater magnitude: JLO (rs=-.70, P=.0005), SDMT (rs=-.73, P=.0001), CVLT DR (rs=-.061, P=.003). Additional significant correlations obtained only at 3T included the 2 second-paced auditory serial addition test (rs=-.55, P=.01), the Brief Visuospatial Memory Test-Delayed Free Recall (rs=-.56, P=.007), and the California Verbal Learning Test TotalRecall (rs=-.42, P=.05). CONCLUSION: MRI at 3T may boost sensitivity and improve validity in MS brain lesion assessment.
Authors: R H Lazeron; D W Langdon; M Filippi; J H van Waesberghe; V L Stevenson; J B Boringa; D Origgi; A J Thompson; M Falautano; C H Polman; F Barkhof Journal: Mult Scler Date: 2000-08 Impact factor: 6.312
Authors: R A Sperling; C R Guttmann; M J Hohol; S K Warfield; M Jakab; M Parente; E L Diamond; K R Daffner; M J Olek; E J Orav; R Kikinis; F A Jolesz; H L Weiner Journal: Arch Neurol Date: 2001-01
Authors: Ralph H B Benedict; Jill S Fischer; Cate J Archibald; Peter A Arnett; William W Beatty; Julie Bobholz; Gordon J Chelune; John D Fisk; Dawn W Langdon; Lauren Caruso; Fred Foley; Nicholas G LaRocca; Lindsey Vowels; Amy Weinstein; John DeLuca; Stephen M Rao; Frederick Munschauer Journal: Clin Neuropsychol Date: 2002-08 Impact factor: 3.535
Authors: M Rovaris; G Riccitelli; E Judica; F Possa; D Caputo; A Ghezzi; A Bertolotto; R Capra; M Falautano; F Mattioli; V Martinelli; G Comi; M Filippi Journal: Neurology Date: 2008-09-24 Impact factor: 9.910
Authors: Mohit Neema; Daniel Goldberg-Zimring; Zachary D Guss; Brian C Healy; Charles R G Guttmann; Maria K Houtchens; Howard L Weiner; Mark A Horsfield; David B Hackney; David C Alsop; Rohit Bakshi Journal: Neuroimage Date: 2009-03-10 Impact factor: 6.556
Authors: Nancy L Sicotte; Rhonda R Voskuhl; Seth Bouvier; Rochelle Klutch; Mark S Cohen; John C Mazziotta Journal: Invest Radiol Date: 2003-07 Impact factor: 6.016
Authors: Z Campbell; D Sahm; K Donohue; J Jamison; M Davis; C Pellicano; S Auh; J Ohayon; J A Frank; N Richert; F Bagnato Journal: Neurology Date: 2012-04-25 Impact factor: 9.910
Authors: M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law Journal: AJNR Am J Neuroradiol Date: 2011-10-20 Impact factor: 3.825
Authors: Laura B Zahodne; Elizabeth Rose Mayeda; Timothy J Hohman; Evan Fletcher; Annie M Racine; Brandon Gavett; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman; Dan Mungas Journal: Neurobiol Aging Date: 2019-08-14 Impact factor: 4.673
Authors: Adolf Pfefferbaum; Torsten Rohlfing; Margaret J Rosenbloom; Weiwei Chu; Ian M Colrain; Edith V Sullivan Journal: Neuroimage Date: 2012-10-12 Impact factor: 6.556